AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionBollard Group LLC
Latest Disclosed Ownership2,195 shares
Latest Disclosed Value $ 477
Bollard Group LLC reports 0.73% increase in ownership of 4AB / AbbVie Inc.

On May 14, 2026 - Bollard Group LLC filed a 13F-HR form disclosing ownership of 2,195 shares of AbbVie Inc. (BG:4AB) valued at $477 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 2,179 shares of AbbVie Inc..

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ABBVIE COM 00287Y109 2,195 16 0.73 0 0.0141
2026-02-13 2025-12-31 13F ABBVIE COM 00287Y109 2,179 1 0.05 0 0.0124
2025-11-14 2025-09-30 13F ABBVIE COM 00287Y109 2,178 1 0.05 1 0.0118
2025-08-13 2025-06-30 13F AbbVie COM 00287Y109 2,177 102 4.92 0 0.0092
2025-05-15 2025-03-31 13F AbbVie COM 00287Y109 2,075 1 0.05 0 0.0114
2025-02-14 2024-12-31 13F AbbVie COM 00287Y109 2,074 -188 -8.31 0 0.0102
2024-11-13 2024-09-30 13F AbbVie COM 00287Y109 2,262 2 0.09 0 0.0119
2024-08-14 2024-06-30 13F AbbVie COM 00287Y109 2,260 -1,363 -37.62 0 0.0109
2024-05-13 2024-03-31 13F AbbVie COM 00287Y109 3,623 -243 -6.29 1 0.0200
2024-02-13 2023-12-31 13F AbbVie COM 00287Y109 3,866 -722 -15.74 1 0.0208
2023-11-14 2023-09-30 13F AbbVie COM 00287Y109 4,588 25 0.55 1 0.0252
2023-08-14 2023-06-30 13F AbbVie COM 00287Y109 4,563 151 3.42 1 0.0209
2023-05-12 2023-03-31 13F AbbVie COM 00287Y109 4,412 23 0.52 1 0.0254
2023-02-10 2022-12-31 13F AbbVie COM 00287Y109 4,389 23 0.53 1 -100.00 0.0271
2022-11-09 2022-09-30 13F AbbVie COM 00287Y109 4,366 24 0.55 586 -11.88 0.0246
2022-08-12 2022-06-30 13F AbbVie COM 00287Y109 4,342 22 0.51 665 -5.00 0.0269
2022-05-12 2022-03-31 13F AbbVie COM 00287Y109 4,320 24 0.56 700 20.27 0.0224
2022-02-11 2021-12-31 13F AbbVie COM 00287Y109 4,296 26 0.61 582 26.25 0.0186
2021-11-12 2021-09-30 13F AbbVie COM 00287Y109 4,270 26 0.61 461 -3.56 0.0151
2021-08-12 2021-06-30 13F AbbVie COM 00287Y109 4,244 25 0.59 478 4.60 0.0152
2021-05-11 2021-03-31 13F AbbVie COM 00287Y109 4,219 28 0.67 457 1.78 0.0160
2021-02-04 2020-12-31 13F AbbVie COM 00287Y109 4,191 27 0.65 449 23.01 0.0167
2020-11-12 2020-09-30 13F AbbVie COM 00287Y109 4,164 28 0.68 365 -10.10 0.0132
2020-08-13 2020-06-30 13F AbbVie COM 00287Y109 4,136 28 0.68 406 29.71 0.0160
2020-05-14 2020-03-31 13F AbbVie COM 00287Y109 4,108 26 0.64 313 -13.30 0.0139
2020-02-10 2019-12-31 13F AbbVie COM 00287Y109 4,082 27 0.67 361 17.59 0.0117
2019-11-13 2019-09-30 13F AbbVie COM 00287Y109 4,055 34 0.85 307 5.14 0.0108
2019-08-13 2019-06-30 13F AbbVie COM 00287Y109 4,021 28 0.70 292 -9.32 0.0101
2019-05-10 2019-03-31 13F AbbVie COM 00287Y109 3,993 27 0.68 322 -12.02 0.0122
2019-02-05 2018-12-31 13F AbbVie COM 00287Y109 3,966 121 3.15 366 0.55 0.0161
2018-11-08 2018-09-30 13F AbbVie COM 00287Y109 3,845 20 0.52 364 2.82 0.0146
2018-08-09 2018-06-30 13F AbbVie COM 00287Y109 3,825 18 0.47 354 -1.67 0.0163
2018-05-14 2018-03-31 13F AbbVie COM 00287Y109 3,807 13 0.34 360 -1.91 0.0179
2018-01-29 2017-12-31 13F AbbVie COM 00287Y109 3,794 13 0.34 367 9.23 0.0176
2017-10-27 2017-09-30 13F AbbVie COM 00287Y109 3,781 17 0.45 336 23.08 0.0177
2017-07-19 2017-06-30 13F AbbVie COM 00287Y109 3,764 19 0.51 273 11.89 0.0147
2017-04-19 2017-03-31 13F Abbvie COM 00287Y109 3,745 20 0.54 244 4.72 0.0140
2017-01-25 2016-12-31 13F Abbvie COM 00287Y109 3,725 16 0.43 233 -0.43 0.0152
2016-10-26 2016-09-30 13F Abbvie COM 00287Y109 3,709 16 0.43 234 2.18 0.0150
2016-07-20 2016-06-30 13F Abbvie COM 00287Y109 3,693 17 0.46 229 9.05 0.0156
2016-05-09 2016-03-31 13F Abbvie COM 00287Y109 3,676 19 0.52 210 -3.23 0.0169
2016-02-04 2015-12-31 13F Abbvie COM 00287Y109 3,657 15 0.41 217 9.60 0.0179
2015-10-30 2015-09-30 13F Abbvie COM 00287Y109 3,642 1,813 99.13 198 60.98 0.0162
2015-08-12 2015-06-30 13F Abbvie COM 00287Y109 1,829 14 0.77 123 16.04 0.0093
2015-05-12 2015-03-31 13F Abbvie COM 00287Y109 1,815 15 0.83 106 -10.17 0.0079
2015-02-12 2014-12-31 13F Abbvie COM 00287Y109 1,800 0 0.00 118 13.46 0.0104
2014-11-14 2014-09-30 13F Abbvie COM 00287Y109 1,800 0 0.00 104 1.96 0.0098
2014-08-13 2014-06-30 13F Abbvie COM 00287Y109 1,800 0 0.00 102 9.68 0.0099
2014-05-14 2014-03-31 13F Abbvie COM 00287Y109 1,800 0 0.00 93 -2.11 0.0094
2014-02-13 2013-12-31 13F Abbvie COM 00287Y109 1,800 0 0.00 95 17.28 0.0105
2013-11-12 2013-09-30 13F/A-1 Abbvie COM 00287Y109 1,800 1,800 81 0.0095
2013-11-05 2013-09-30 13F Abbvie COM 00287Y109 1,800 81 0.0095
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.